Enhanced Investments - Financial Portal

Published: 2023-02-14 07:00:15 ET

EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1

Exhibit 99.1

InMode Reports Fourth Quarter and Full Year 2022 Financial Results; Record Quarterly

Revenue of $133.6M Represents 21% Year-Over-Year Growth

YOKNEAM, Israel, Feb. 14, 2023- InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year ended December 31, 2022.

Fourth Quarter 2022 Highlights:

	● Record quarterly revenue of $133.6 million, an increase of 21% compared to the fourth quarter of 2021. InMode’s proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments represented 83% of quarterly revenues, while 9% came from InMode’s hands-free platforms and 8% from InMode’s traditional laser and non-invasive RF platforms.
	● GAAP net income of $37.7 million, compared to $52.7 million in the fourth quarter of 2021; record *non-GAAP net income of $66.4 million, compared to $55.2 million in the fourth quarter of 2021.
	● GAAP diluted earnings per share of $0.44, compared to $0.61 in the fourth quarter of 2021; record *non-GAAP diluted earnings per share of $0.78, compared to $0.64 in the fourth quarter of 2021.
	● Record quarterly revenues from consumables and service of $17.1 million, an increase of 43% compared to the fourth quarter of 2021.

Full Year 2022 Highlights:

●

Record full year revenues of $454.3 million, an increase of 27% as compared to 2021; 81% of revenues derived from our proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments, 10% from our hands-free platforms and 9% from our traditional laser and non-invasive RF platforms

●

GAAP net income of $161.5 million, compared to $165 million in 2021; record *non-GAAP net income of $207.5 million, compared to $176.3 million in 2021

●

GAAP diluted earnings per share of $1.89, compared to $1.92 in 2021; record *non-GAAP diluted earnings per share of $2.42, compared to $2.05 in 2021

●

29% increase in international (non-U.S.) revenues as compared to 2021

U.S. GAAP Results (U.S. dollars in thousands, except for per share data)
	Q4 2022	Q4 2021	FY 2022	FY 2021
Revenues	$133,571	$110,540	$454,271	$357,565
Gross Margins	84%	85%	84%	85%
Net Income Attributable to InMode Ltd.	$37,708	$52,685	$161,520	$164,971
Earnings per Diluted Share	$0.44	$0.61	$1.89	$1.92
*Non-GAAP Results (U.S. dollars in thousands, except for per share data)
	Q4 2022	Q4 2021	FY 2022	FY 2021
Gross Margins	85%	85%	84%	85%
Net Income Attributable to InMode Ltd.	$66,370	$55,193	$207,486	$176,317
Earnings per Diluted Share	$0.78	$0.64	$2.42	$2.05

*Please refer to “Use of Non-GAAP Financial Measures” below for important information about non-GAAP financial measures. Non-GAAP financial results exclude share-based compensation and certain tax adjustments. The Company applied the provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of $12.0 million to the Israeli Tax Authority. In addition, the Company reached agreement with the Israeli Tax Authority under which the Company paid during January 2023 approximately $14.3 million on its undistributed exempt income for the year ended December 31, 2021. As a result, approximately $313.2 million of the Company’s undistributed exempt income for years 2012 through 2021 may be distributed or used by the Company without being subject to additional corporate tax.

Management Comments

“We are happy to report another record revenue year and continuously high profitable growth as we scale globally and reach a yearly revenue run rate nearing $500 million. We are also very happy with the successful launch of the Empower RF, and we remain focused on expanding into additional aesthetic and wellness categories. We are proud to have successfully navigated through the worldwide supply chain challenges in 2022, therefore fulfilling customer orders on time,” said Moshe Mizrahy, Chairman and Chief Executive Officer.

Shakil Lakhani, President of InMode North America, commented, “This year demonstrated InMode’s ability to expand into new categories and solidified our leadership position in the aesthetics and wellness markets. As our platform sales benefit from a strengthening brand awareness, we also experienced a significant increase in our consumable sales, having sold over 230,000 consumables in the fourth quarter. To further support this market demand, we continue adding talent to our team in North America this year.”

“The solid endorsement of the EmpowerRF platform significantly surpassed our most optimistic expectations for the year. Currently, we are conducting six clinical studies focusing on how this technology can positively impact a wide range of health issues for women. In addition, as we continue our strategy and expand into new areas of wellness, we plan to launch the Envision platform for the ophthalmology market during the first half of 2023, followed by the second generation of our hands-free platform for face treatments during the latter half of the year,” said Dr. Spero Theodorou, Chief Medical Officer.

Fourth Quarter 2022 Financial Results

Total revenues for the fourth quarter of 2022 reached $133.6 million, an increase of 21% compared to the fourth quarter of 2021.

“We are proud to report another record quarter and year for total revenue, while again maintaining the target gross margin range of over 84%. This derives from our ability to control expenses during global supply chain constraints, while decisively responding to high demand and ensuring orders are delivered on time. Once again, we saw strength from our international operations in the quarter, and we expect that this trend will continue,” said Yair Malca, Chief Financial Officer.

InMode applied the provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of $12.0 million to the Israeli Tax Authority. In addition, the Company reached agreement with the Israeli Tax Authority under which the Company paid during January 2023 approximately $14.3 million on its undistributed exempt income for the year ended December 31, 2021.

“I am very pleased that as a result, approximately $313.2 million of the Company’s undistributed exempt income for years 2012 through 2021 may be distributed or used without being subject to additional corporate tax,” Malca concluded.

GAAP gross margin for the fourth quarter of 2022 was 84% compared to a gross margin of 85% in the fourth quarter of 2021. *Non-GAAP gross margin for the fourth quarter of 2022 and 2021 was 85%.

GAAP operating margin for the fourth quarter of 2022 was 45%, compared to an operating margin of 49% in the fourth quarter of 2021. *Non-GAAP operating margin for the fourth quarter of 2022 was 50% and for the fourth quarter of 2021 was 51%. The decrease in GAAP operating margin is primarily attributable to change in share-based compensation expense.

InMode reported GAAP net income of $37.7 million, or $0.44 per diluted share, in the fourth quarter of 2022, compared to $52.7 million, or $0.61 per diluted share, in the fourth quarter of 2021. On a *non-GAAP basis, InMode reported net income of $66.4 million, or $0.78 per diluted share, in the fourth quarter of 2022, compared to $55.2 million, or $0.64 per diluted share, in the fourth quarter of 2021. The decrease in GAAP net income is primarily attributable to undistributed exempt income.

Full Year 2022 Financial Results

Total revenues for 2022 were $454.3 million, an increase of 27% as compared to 2021. This increase was primarily attributable to strong demand for our minimally invasive platforms. In addition, InMode gained traction in international markets, with international revenues growing 29% year over year.

GAAP gross margin for 2022 was 84%, and the gross margin in 2021 was 85%. *Non-GAAP gross margin for 2022 was 84% and the gross margin in 2021 was 85%.

GAAP operating margin for 2022 was 44%, compared to the operating margin of 47% in 2021. *Non-GAAP operating margin for 2022 was 49%, compared to the operating margin of 50% in the full year of 2021. The decrease in GAAP operating margin is primarily attributable to a change in share-based compensation expense.

InMode reported GAAP net income attributable to InMode Ltd. of $161.5 million, or $1.89 per diluted share, in 2022. This is compared with GAAP net income attributable to InMode Ltd of $165 million, or $1.92 per diluted share, in 2021. On a *non-GAAP basis, InMode reported net income attributable to InMode Ltd. of $207.5 million, or $2.42 per diluted share, in the full year of 2022, compared to net income attributable to InMode Ltd. of $176.3 million, or $2.05 per diluted share, in the full year of 2021.

As of December 31, 2022, InMode had cash and cash equivalents, marketable securities, and short-term bank deposits of $547.4 million.

2023 Financial Outlook

Management provided an outlook for the full year of 2023 ending December 31, 2023. Based on current estimates, management expects:

●	Revenue between $525 million and $530 million

●	*Non-GAAP gross margin between 83% and 85%

●	*Non-GAAP income from operations between $236 million and $238 million

●	*Non-GAAP earnings per diluted share between $2.58 and $2.60

This outlook is not a guarantee of future performance and stockholders should not rely on such forward-looking statements. See “Forward-Looking Statements” for additional information.

*Please refer to “Use of Non-GAAP Financial Measures” below for important information about non-GAAP financial measures. Non-GAAP financial results exclude share-based compensation and certain tax adjustments. The Company applied the provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of $12.0 million to the Israeli Tax Authority. In addition, the Company reached agreement with the Israeli Tax Authority under which the Company Paid during January 2023 approximately $14.3 million on its undistributed exempt income for the year ended December 31, 2021. As a result, approximately $313.2 million of the Company’s undistributed exempt income for years 2012 through 2021 may be distributed or used by the Company without being subject to additional corporate tax.

Use of Non-GAAP Financial Measures

In addition to InMode’s operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, and non-GAAP operating margin. Because these measures are used in InMode’s internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode’s economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode’s GAAP operating results, allows investors to more effectively evaluate and compare InMode’s performance to that of its peers, although InMode’s presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release.

Conference Call Information

Mr. Moshe Mizrahy, Chairman and Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer, Mr. Yair Malca, Chief Financial Officer, Mr. Shakil Lakhani, President of North America, and Dr. Spero Theodorou, Chief Medical Officer, will host a conference call today, February 14, 2023, at 8:30 a.m. Eastern Time to discuss the fourth quarter 2022 financial results.

The Company encourages participants to pre-register for the conference call using the following link:

https://dpregister.com/sreg/10174372/f5819ac374

Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.

U.S. Toll-Free Dial-in Number: 1-833-316-0562

Israel Toll- Free Dial-in Number: 1-80-921-2373

International Dial-in Number: 1-412-317-5736

Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=JnMDK7VQ

At:

8:30 a.m. Eastern Time

5:30 a.m. Pacific Time

3:30 p.m. Israel Time

The conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from February 14, 2023, at 12 p.m. Eastern Time to February 28, 2023, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers:

Replay Dial-in U.S TOLL-FREE: 1-877-344-7529

Replay Dial-in Canada TOLL-FREE: 855-669-9658

Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088

Replay Pin Number: 3700075

To access the replay using an international dial-in number, please select the link below:

https://services.choruscall.com/ccforms/replay.html

A replay of the conference call will also be available for 90 days on InMode's website at https://inmodemd.com/investors/.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures and markets devices harnessing novel radio frequency (“RF”) technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode’s future financial or operating performance, including the future performance described above under the heading titled “2021 Financial Outlook.” Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict, including with respect to the impact of the COVID-19 global outbreak. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2022, as well as risk factors relating to the COVID-19 global outbreak and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Company Contact:

Yair Malca

Chief Financial Officer

Phone: (949) 305-0108

Email: Yair.Malca@inmodemd.com

Investor Relations Contact:

Miri Segal

MS-IR LLC

Phone: (917) 607-8654

Email: ir@inmodemd.com

INMODE LTD.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(U.S. dollars in thousands, except for per share data)

(Unaudited)

	Three months ended December 31,					Year Ended December 31,
	2022		2021			2022		2021
REVENUES		133,571		110,540			454,271		357,565
COST OF REVENUES		21,002		16,847			73,485		53,592
GROSS PROFIT		112,569		93,693			380,786		303,973
OPERATING EXPENSES:
Research and development		3,261		2,528			12,425		9,532
Sales and marketing		47,012		35,286			160,576		119,353
General and administrative		2,398		2,527			9,931		8,411
Other Income		-		(800	)		-		(800	)
TOTAL OPERATING EXPENSES		52,671		39,541			182,932		136,496
INCOME FROM OPERATIONS		59,898		54,152			197,854		167,477
Finance income, net		3,962		118			3,612		525
INCOME BEFORE TAXES		63,860		54,270			201,466		168,002
INCOME TAXES		26,152		1,585			39,946		2,928
NET INCOME		37,708		52,685			161,520		165,074
Less: net income attributable to non-controlling interests		-		-			-		(103	)
NET INCOME ATTRIBUTABLE TO INMODE LTD.		37,708		52,685			161,520		164,971

NET INCOME PER SHARE:
Basic		0.46		0.63			1.96		2.03
Diluted		0.44		0.61			1.89		1.92
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands)
Basic		82,449		83,234			82,482		81,445
Diluted		85,288		86,384			85,404		86,017

INMODE LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands, except for per share data)

(Unaudited)

	December 31, 2022		December 31, 2021
Assets
CURRENT ASSETS:
Cash and cash equivalents		97,540		68,136
Marketable securities (amortized cost of $384,321 and $296,243, as of December 31, 2022 and 2021, respectively)		374,589		294,530
Short-term bank deposits		75,254		53,248
Accounts receivable, net of allowance for credit losses of $836 and $1,107, as of December 31, 2022 and 2021, respectively		26,997		20,236
Other receivables		15,094		12,938
Inventories		39,897		21,026
TOTAL CURRENT ASSETS		629,371		470,114
NON-CURRENT ASSETS:
Accounts receivable net of allowance for credit losses of $482 and $0 at December 31, 2022 and 2021, respectively		3,973		768
Deferred income tax asset, net		3,094		1,334
Operating lease right-of-use assets		5,073		4,321
Property and equipment, net		2,298		1,404
Other investments		600		600
TOTAL NON-CURRENT ASSETS		15,038		8,427
TOTAL ASSETS		644,409		478,541
Liabilities and shareholders’ equity
CURRENT LIABILITIES:
Accounts payable		16,242		8,779
Contract liabilities		13,798		13,805
Other liabilities		51,980		29,266
TOTAL CURRENT LIABILITIES		82,020		51,850
NON-CURRENT LIABILITIES:
Contract liabilities		3,959		2,751
Other liabilities		303		4,831
Operating lease liabilities		3,509		3,307
TOTAL NON-CURRENT LIABILITIES		7,771		10,889
TOTAL LIABILITIES		89,791		62,739

TOTAL SHAREHOLDERS’ EQUITY		554,618		415,802
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		644,409		478,541

INMODE LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands, except for per share data)

(Unaudited)

	Three months ended December 31,						Year Ended December 31,
	2022			2021			2022			2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		37,708			52,685			161,520			165,074
Adjustments required to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		218			139			680			517
Share-based compensation expenses		7,148			3,124			24,452			11,962
Change in allowance for credit losses of trade receivable		47			141			449			516
Loss on marketable securities, net		22			142			71			175
Finance expenses (income), net		(2,737	)		(375	)		(1,210	)		1,223
Deferred income taxes, net		(72	)		(379	)		84			(770	)
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable		805			1,934			(10,415	)		(10,544	)
Increase in other receivables		(1,081	)		(1,982	)		(1,787	)		(6,400	)
Increase in inventories		(4,087	)		(1,848	)		(18,871	)		(6,043	)
Increase (decrease) in accounts payable		2,946			(105	)		7,463			2,369
Increase (decrease) in other liabilities		14,575			(2,056	)		17,941			14,138
Increase in contract liabilities		1,660			1,473			1,201			2,668
Net cash provided by operating activities		57,152			52,893			181,578			174,885
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in short-term deposits		-			(7,000	)		(93,701	)		(73,090	)
Proceeds from short-term deposits		-			7,000			73,090			69,180
Purchase of fixed assets		(328	)		(182	)		(1,575	)		(939	)
Purchase of marketable securities		(70,944	)		(70,560	)		(168,680	)		(273,834	)
Proceeds from sale of marketable securities		-			33,785			2,303			93,652
Proceeds from maturity of marketable securities		32,997			6,150			79,089			24,925
Net cash used in investing activities		(38,275	)		(30,807	)		(109,474	)		(160,106	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repurchase of ordinary shares		-			(23,444	)		(42,637	)		(35,365	)
Exercise of options		637			540			1,552			20,343
Net cash provided by (used in) financing activities		637			(22,904	)		(41,085	)		(15,022	)
EFFECT OF EXCHANGE RATE CHANGES ON CASH		978			26			(1,615	)		(559	)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		20,492			(792	)		29,404			(802	)

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		77,048			68,928			68,136			68,938
CASH AND CASH EQUIVALENTS AT END OF PERIOD		97,540			68,136			97,540			68,136

INMODE LTD.

CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS

(U.S. dollars in thousands, except for per share data)

(Unaudited)

	Three months ended December 31,								Year Ended December 31,
	2022				2021				2022				2021
Revenues by Category:

Capital Equipment revenues - United States		80,352	60	%		66,810	60	%		260,992	58	%		211,424	59	%
Capital Equipment revenues - International		36,094	27	%		31,785	29	%		133,220	29	%		107,815	30	%
Total Capital Equipment revenues		116,446	87	%		98,595	89	%		394,212	87	%		319,239	89	%
Consumables and service revenues		17,125	13	%		11,945	11	%		60,059	13	%		38,326	11	%
Total Net Revenue		133,571	100	%		110,540	100	%		454,271	100	%		357,565	100	%

	Three months ended December 31,												Year Ended December 31,
	2022						2021						2022						2021
	%						%						%						%
	United States		International		Total		United States		International		Total		United States		International		Total		United States		International		Total
Revenues by Technology:
Minimally Invasive		86		76		83		74		70		73		85		74		81		71		73		72
Hands-Free		11		4		9		23		6		17		12		6		10		27		7		20
Non-Invasive		3		20		8		3		24		10		3		20		9		2		20		8
		100		100		100		100		100		100		100		100		100		100		100		100

INMODE LTD.

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF

INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(U.S. dollars in thousands, except for per share data)

(Unaudited)

	Three months ended December 31, 2022										Three months ended December 31, 2021
	GAAP		Share Based Compensation			Undistributed Exempt Income			Non-GAAP		GAAP			Share Based Compensation			Other Income Related to IP Transactions			Non-GAAP
REVENUES		133,571		-			-			133,571		110,540			-			-			110,540
COST OF REVENUES		21,002		(553	)		-			20,449		16,847			(304	)		-			16,543
GROSS PROFIT		112,569		553			-			113,122		93,693			304			-			93,997
OPERATING EXPENSES:
Research and development		3,261		(918	)		-			2,343		2,528			(442	)		-			2,086
Sales and marketing		47,012		(5,069	)		-			41,943		35,286			(2,120	)		-			33,166
General and administrative		2,398		(608	)		-			1,790		2,527			(258	)		-			2,269
Other Income		-		-			-			-		(800	)		-			800			-
TOTAL OPERATING EXPENSES		52,671		(6,595	)		-			46,076		39,541			(2,820	)		800			37,521
INCOME FROM OPERATIONS		59,898		7,148			-			67,046		54,152			3,124			(800	)		56,476
Finance income, net		3,962		-			-			3,962		118						-			118
INCOME BEFORE TAXES		63,860		7,148			-			71,008		54,270			3,124			(800	)		56,594
INCOME TAXES		26,152		-			(21,514	)		4,638		1,585						(184	)		1,401
NET INCOME		37,708		7,148			21,514			66,370		52,685			3,124			(616	)		55,193

NET INCOME PER SHARE:
Basic		0.46								0.80		0.63									0.66
Diluted		0.44								0.78		0.61									0.64
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands)
Basic		82,449								82,449		83,234									83,234
Diluted		85,288								85,515		86,384									86,519

INMODE LTD.

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF

INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(U.S. dollars in thousands, except for per share data)

(Unaudited)

	Year Ended December 31, 2022										Year Ended December 31, 2021
	GAAP		Share Based Compensation			Undistributed Exempt Income			Non-GAAP		GAAP			Share Based Compensation			Other Income Related to IP Transactions			Non-GAAP
REVENUES		454,271		-			-			454,271		357,565			-			-			357,565
COST OF REVENUES		73,485		(1,917	)		-			71,568		53,592			(1,108	)		-			52,484
GROSS PROFIT		380,786		1,917			-			382,703		303,973			1,108						305,081
OPERATING EXPENSES:
Research and development		12,425		(3,166	)		-			9,259		9,532			(1,554	)		-			7,978
Sales and marketing		160,576		(17,302	)		-			143,274		119,353			(8,274	)		-			111,079
General and administrative		9,931		(2,067	)		-			7,864		8,411			(1,026	)		-			7,385
Other Income		-		-			-			-		(800	)		-			800			-
TOTAL OPERATING EXPENSES		182,932		(22,535	)		-			160,397		136,496			(10,854	)		800			126,442
INCOME FROM OPERATIONS		197,854		24,452			-			222,306		167,477			11,962			(800	)		178,639
Finance income, net		3,612		-			-			3,612		525			-			-			525
INCOME BEFORE TAXES		201,466		24,452			-			225,918		168,002			11,962			(800	)		179,164
INCOME TAXES (TAX BENEFIT)		39,946		-			(21,514	)		18,432		2,928			-			(184	)		2,744
NET INCOME		161,520		24,452			21,514			207,486		165,074			11,962			(616	)		176,420
Less: net income attributable to non-controlling interests		-		-			-			-		(103	)		-			-			(103	)
NET INCOME ATTRIBUTABLE TO INMODE LTD.		161,520		24,452			21,514			207,486		164,971			11,962			(616	)		176,317

NET INCOME PER SHARE:
Basic		1.96								2.52		2.03									2.16
Diluted		1.89								2.42		1.92									2.05
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands)
Basic		82,482								82,482		81,445									81,445
Diluted		85,404								85,628		86,017									86,192

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.